Skip to main content
OpenTrials
Completed

NCT Number: NCT00906581

Self-guided Depression Treatment on Long-duration Spaceflights: A Continuation Study

Use of a computer-based treatment will reduce level of depression.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02120, United States

About this study

Objective Depression can present a significant threat to long-duration space missions, and crews need the ability to recognize it and treat it effectively. We are developing a prototype computer-based system that includes a module for the recognition and treatment of depression. Before being used by astronauts, this system needs to be further developed and tested for efficacy in an analog population. The countermeasure we are developing is intended for use both in pre-flight training and on the International Space Station. The program has substantial Earth benefits.

Aims

  • Complete development of the module for recognizing and preventing depression. We will complete this module, moving from the prototype stage to a completed computer-based tool. We will modify the design based on data from our usability and acceptability study with astronauts at NASA Johnson Space Center. We will pilot-test the module with five participants and make revisions based on their input.
  • Develop the module for implementing computer-based Problem-Solving Treatment (PST). Currently, problem-solving treatment is done using a practitioner who guides the patient through this structured therapy and follows their progress. These practitioners are trained to administer the therapy through a formalized training program that incorporates a workbook and instructional videos. These materials are well suited for presentation via multimedia on computers to make the treatment self-guided. The PST intervention will be modified from its current video/workbook form to a computer-based form that can be used by astronauts or other professionals who are suffering from depression.
  • Evaluate the efficacy of the computer-delivered PST module for depression in a randomized, controlled trial. Hypotheses related to this aim are that, compared to a waiting-list control:
  • Individuals receiving computer-delivered PST will show a greater reduction in depression symptoms, as rated by a clinician.
  • Individuals receiving computer-delivered PST will show a greater reduction in depression, as rated by self-report.
  • A greater proportion of individuals receiving computer-delivered PST will have remitted at post-treatment.

Earth-based Applications of Research Project Depression is widespread, and effective treatments are not available to all persons who have it. This computer-based depression treatment, with simple modifications and revisions, could be adapted for use in other isolated, operational environments, such as polar research stations, submarines, commercial ships, oil rigs and underwater research facilities. Furthermore, even greater value could be derived by making similar psychosocial support systems available to the public in settings such as primary care practices, public and mental health centers, schools, social services offices, places of worship, military bases, prisons, and eventually at home or in any location, through broadband Internet.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Criteria for matching to astronaut corps population:
  • Completed 4 or more years of college or university education
  • Age 30-60
  • Has access to a personal computer and regularly uses it (at least twice per week)
  • Clinical criteria:
  • Score of 10 or higher on Hamilton Depression Inventory (which yields equivalent scores to the Hamilton Depression Rating Scale).
  • Has a diagnosis of minor depression consisting of 2 to 4 DSM-IV symptoms of depression, one of which is depressed mood or anhedonia
  • Presence of depressive symptoms for at least 2 weeks but less than 2 years
  • Patient willing to avoid or postpone the use of antidepressant drugs during the treatment portion of the study (6 weeks)

Exclusion criteria

  • Presence of more severe depression or dysthymia within the past 6 months (to rule out persons currently remitting from major depression)
  • Current or past diagnosis of organic mental disorder, schizophrenia, bipolar disorder, or current psychotic symptoms
  • Current suicidal ideation or any history of suicide attempt or self-injurious behavior
  • Presence of comorbid antisocial personality disorder
  • Any current substance abuse/dependence (other than nicotine or caffeine)
  • Suicidal ideation or parasuicidality
  • Current homicidal ideation
  • Recent regimen changes within the past 2 months in prescribed antidepressants, benzodiazepines, or buspirone
  • Currently receiving psychotherapy or mental health counseling
  • Exposure to PST in previous studies
  • Moderate or sever cognitive impairment (Mini Mental State Score <= 23)
  • Near terminal medical illness (physician estimates < 6 months to live)

Treatment and study plan

Computer-based Problem-Solving Treatment

Behavioral

6 sessions of problem-solving treatment delivered via computer

Primary outcomes

  1. Hamilton Depression Inventory

    Time frame: Pre and post-intervention

Sponsors and collaborators

Lead sponsor

Beth Israel Deaconess Medical Center

Other

Collaborators

  • Dartmouth-Hitchcock Medical Center
  • National Space Biomedical Research Institute

Registry information

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
May 21, 2009
Registry last updated
Apr 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.